Spain’s Supreme Court ruled earlier this month that migrants intercepted at sea while attempting to reach Ceuta or Melilla cannot be summarily returned under the enclaves’ special border-rejecti
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).